Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FATEN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $2,082.93 to DMS Pharmaceutical Group Inc. for 68 mg Nexplanon implants, a subdermal contraceptive device. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. The delivery order carries an ultimate completion date of November 10, 2025, and represents one of numerous pharmaceutical supply orders issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. This contract positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FATEN?
SPE2DB26FATEN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FATEN worth?
The government has obligated $2,083 on SPE2DB26FATEN.
Is contract SPE2DB26FATEN an order under another contract?
Yes. SPE2DB26FATEN is a delivery order under SPE2DB24D9228, an indefinite delivery contract.
Was contract SPE2DB26FATEN competed?
The extent of competition for SPE2DB26FATEN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award